OncoDiag Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 8

OncoDiag General Information

Description

Developer of non-invasive diagnostic testing kits designed to help in the early detection of urological cancers. The company's testing kits consist of a urine-based lab test for the surveillance of bladder cancer, a tissue-based lab test to predict non-evolutive localized prostate cancer, and a blood-based lab test for screening colorectal cancer, enabling doctors to effectively proceed in cancer diagnostics.

Contact Information

Website
www.oncodiag.fr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 251 Rue Clément Ader
  • Building A (door 9), Evreux
  • 27000 Miserey
  • France
+33 02
Primary Industry
Diagnostic Equipment
Other Industries
Clinics/Outpatient Services
Biotechnology
Vertical(s)
Corporate Office
  • 251 Rue Clément Ader
  • Building A (door 9), Evreux
  • 27000 Miserey
  • France
+33 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoDiag Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 07-Jun-2022 Completed Generating Revenue
5. Later Stage VC (Series A) 15-Mar-2021 Completed Generating Revenue
4. Angel (individual) 14-Dec-2018 Completed Generating Revenue
3. Angel (individual) 06-Jun-2017 Completed Generating Revenue
2. Accelerator/Incubator 05-Jun-2014 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view OncoDiag’s complete valuation and funding history, request access »

OncoDiag Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 9,300 $1.204024 $24.08 $24.08 1x $24.08 5.96%
To view OncoDiag’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

OncoDiag Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of non-invasive diagnostic testing kits designed to help in the early detection of urological cancers. The com
Diagnostic Equipment
Miserey, France
7 As of 2026

Hayward, CA
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OncoDiag Competitors (4)

One of OncoDiag’s 4 competitors is DiaCarta, a Venture Capital-Backed company based in Hayward, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DiaCarta Venture Capital-Backed Hayward, CA
Owlstone Medical Venture Capital-Backed Cambridge, United Kingdom
Nucleix Venture Capital-Backed Rehovot, Israel
Biodesix Formerly VC-backed Louisville, CO
To view OncoDiag’s complete competitors history, request access »

OncoDiag Patents

OncoDiag Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026093495-A1 Methods for the diagnosis of prostate cancer Pending 31-Oct-2024
WO-2024208824-A1 Methods for the diagnosis and surveillance of cancer Inactive 03-Apr-2023
ES-2730710-T3 Methods for surveillance, diagnosis and exploration of bladder cancer (bladder) Active 19-Nov-2013
AU-2014352012-A1 Methods for the surveillance, diagnosis and screening of bladder cancer Active 19-Nov-2013
AU-2014352012-B2 Methods for the surveillance, diagnosis and screening of bladder cancer Inactive 19-Nov-2013 C12Q1/6886
To view OncoDiag’s complete patent history, request access »

OncoDiag Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OncoDiag Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
SATT Lutech Accelerator/Incubator
Normandie Participations Venture Capital Minority
Paris Business Angels Angel Group Minority
SFINE Venture Capital Minority
Angels Santé Angel Group Minority
You’re viewing 5 of 8 investors. Get the full list »

OncoDiag FAQs

  • When was OncoDiag founded?

    OncoDiag was founded in 2013.

  • Where is OncoDiag headquartered?

    OncoDiag is headquartered in Miserey, France.

  • What is the size of OncoDiag?

    OncoDiag has 7 total employees.

  • What industry is OncoDiag in?

    OncoDiag’s primary industry is Diagnostic Equipment.

  • Is OncoDiag a private or public company?

    OncoDiag is a Private company.

  • What is OncoDiag’s current revenue?

    The current revenue for OncoDiag is .

  • How much funding has OncoDiag raised over time?

    OncoDiag has raised $4M.

  • Who are OncoDiag’s investors?

    SATT Lutech, Normandie Participations, Paris Business Angels, SFINE, and Angels Santé are 5 of 8 investors who have invested in OncoDiag.

  • Who are OncoDiag’s competitors?

    DiaCarta, Owlstone Medical, Nucleix, and Biodesix are competitors of OncoDiag.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process